5Muto M, Ohtsu A, Miyata Y, et al. Self-expandable metallic stents for patients with recurrent esophageal carcinoma after failure of primary chemoradiotherapy[J]. Jpn J Clin Oncol, 2001031 (6) :270-274.
2Hinojar AG, Castejon MA, Hinojar AA.Conservative management of a case of cervical esophagus perforation with mediastinal abscess and bilateral pleural effusion[J]. Auris Nasus Larynx, 2002,29(2):199-201.
3Kiernan PD, Sheridan MJ, Elster E, et al.Thoracic esophageal perforations[J].South Med J, 2003, 96(2):158-163.
4Port JL, Kent MS, Korst RJ, et al .Thoracic esophageal perforations: a decade of experience[J]. Ann Thorac Surg, 2003, 75(4):1071-1074.
5Morgan RA, Ellul JP, Denton ER, et al. Malignant esophageal fistulas and perforations:management with plastic-covered metallic endoprostheses[J]. Radiology, 1997, 204(2):527-532.
6Muto M,Ohtsu A, Miyata Y, et al. Self-expandable metallic stents for patients with recurrent esophageal carcinoma after failure of primary chemoradiotherapy[J].Jpn J Clin Oncol, 2001,31(6):270-274.
7Dirks K,Schulz T, Schellmann B, et al.Fatal Hemorrhage following perforation of the aorta by a barb of the Gianturco-Rosch esophageal stent[J].Z Gastroenterol, 2002,40(2):81-84.
8Roth J A, Lichter A S, Putnam J B, et al. Cancer of the esophus. In: De Vita VT Jr, Hellman SA, eds. Principles and practice of oncogy[M].6th ed.Lippincott: Philadelphia, 1993:776
9Endo M, Shinbori N, Fukase Y, et al. Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models[J]. Int J Cancer,1999,83(1):127
10Miwa M, Ura M, Nishida K, et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue[J]. Eur J Cancer,1998,34(8):1274
